Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ISRCTN15110009) titled 'Using genetic testing to personalize heart treatment for patients undergoing stent procedures in Qatar' on May 7.
Study Type: Interventional
Study Design:
Prospective interventional study (Prevention, Safety, Efficacy)
Primary Sponsor: Qatar Precision Health Institute
Condition:
Coronary artery disease
Circulatory System
Intervention:
The prospective observation trial included all patients undergoing PCI and requiring dual antiplatelet therapy for 12 months. The prospective genotype-guided strategy (intervention group) will be compared against a retrospective nontailored strategy (control group), which will ...